Hypertension-induced venous valve remodeling
- PMID: 15192576
- DOI: 10.1016/j.jvs.2004.02.044
Hypertension-induced venous valve remodeling
Abstract
Introduction: In human beings, chronic venous insufficiency is linked to venous hypertension. This in turn is associated with venous valve incompetence. This study was designed to test the hypothesis that venous hypertension serves to initiate a process that results in the venous valve and venous wall damage observed in venous insufficiency. Material and methods Acute venous hypertension was produced by creation of an arteriovenous (AV) fistula between the femoral artery and vein in Wistar rats. At specified intervals pressure in the veins was recorded. The proximal valve containing saphenous vein was exposed, and reflux was measured from reverse blood flow through the first proximal valve. The vein was excised, valve parameters were measured, a portion was taken for morphologic investigation, and the remaining specimen was frozen in liquid nitrogen for investigation of leukocyte infiltration, expression of adhesion molecules, matrix metalloproteinase (MMP) levels, and apoptotic markers. Contralateral nonpressurized saphenous veins were used as control specimens.
Results: The saphenous and femoral veins were immediately distended by pulsatile blood flow from the arterial system. Pressure was significantly increased from 11 +/- 2 mm Hg to 94 +/- 9 mm Hg. At 2 days no reflux was detected in the saphenous veins. At 1 week, one of four rats exhibited reflux; at 2 weeks, two of four rats had reflux; and at 3 weeks, three of four rats showed reflux. Contralateral saphenous veins were uniformly competent. Compared with control specimens, the veins were dilated; leaflet length and leaflet width were significantly reduced. Granulocytes, monocytes, and macrophages were identified in all regions of the vein wall, and the number was increased by the presence of the AV fistula. The number of T-lymphocytes was increased, and B-lymphocytes were present. P-selectin was upregulated in the saphenous vein walls, as was intercellular adhesion molecules. MMP-2 and MMP-9 expression in the veins was not enhanced. In the nuclear factor kappabeta family, Ikappabeta was not increased in any hypertensive veins. The number of apoptotic cells in the vein wall was increased in the presence of the AV fistula.
Conclusion: This study indicates that acute venous hypertension is accompanied by significant venous distention and some valve damage as early as 3 weeks after fistula creation. There is development of inflammatory markers, with leukocyte infiltration and increased adhesion molecule expression. We could not detect significant enhancement of MMP levels or nuclear transcription factors. It is uncertain whether this lack of evidence may be partially due to enhanced apoptosis in venous valves and vein walls. A detailed definition of the inflammatory reaction produced by venous hypertension should be the subject of further study. Clinical relevance Saphenous vein valves when observed at the time of vein stripping show deformities of shortening, scarring, and tearing. The current model of induced venous hypertension demonstrates early venous valve changes similar to those observed in human beings and links them to a venous hypertension-induced inflammatory reaction. Thus the model could be useful in pharmacologic testing to prevent or treat venous insufficiency and for defining the fundamental mechanisms that cause varicose veins.
Similar articles
-
An animal model of venous hypertension: the role of inflammation in venous valve failure.J Vasc Surg. 2005 Feb;41(2):303-11. doi: 10.1016/j.jvs.2004.10.038. J Vasc Surg. 2005. PMID: 15768014
-
Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg.Eur J Vasc Endovasc Surg. 2008 Jan;35(1):102-10. doi: 10.1016/j.ejvs.2007.08.011. Epub 2007 Sep 24. Eur J Vasc Endovasc Surg. 2008. PMID: 17890112
-
Venous hypertension, inflammation and valve remodeling.Eur J Vasc Endovasc Surg. 2004 Nov;28(5):484-93. doi: 10.1016/j.ejvs.2004.05.012. Eur J Vasc Endovasc Surg. 2004. PMID: 15465369
-
Pathogenesis of primary chronic venous disease: Insights from animal models of venous hypertension.J Vasc Surg. 2008 Jan;47(1):183-92. doi: 10.1016/j.jvs.2007.09.028. J Vasc Surg. 2008. PMID: 18178472 Review.
-
Microcirculatory dysfunction in chronic venous insufficiency (CVI).Microcirculation. 2000;7(6 Pt 2):S3-12. Microcirculation. 2000. PMID: 11151969 Review.
Cited by
-
Histopathological changes in myocardial tissue due to coronary venous hypertension.Arch Med Sci. 2020 Jan 7;19(6):1714-1720. doi: 10.5114/aoms.2019.91472. eCollection 2023. Arch Med Sci. 2020. PMID: 38058730 Free PMC article.
-
Effect of Trendelenburg's Operation With Subfascial Ligation of Perforators in Clinical Improvement and Quality of Life Among Patients With Varicose Veins.Cureus. 2023 Jul 6;15(7):e41472. doi: 10.7759/cureus.41472. eCollection 2023 Jul. Cureus. 2023. PMID: 37546138 Free PMC article.
-
The Effect of Diosmin, Escin, and Bromelain on Human Endothelial Cells Derived from the Umbilical Vein and the Varicose Vein-A Preliminary Study.Biomedicines. 2023 Jun 13;11(6):1702. doi: 10.3390/biomedicines11061702. Biomedicines. 2023. PMID: 37371797 Free PMC article.
-
Melatonin Alleviates Venous Dysfunction in a Mouse Model of Iliac Vein Occlusion.Front Immunol. 2022 May 2;13:870981. doi: 10.3389/fimmu.2022.870981. eCollection 2022. Front Immunol. 2022. PMID: 35585973 Free PMC article.
-
Interventions for great saphenous vein incompetence.Cochrane Database Syst Rev. 2021 Aug 11;8(8):CD005624. doi: 10.1002/14651858.CD005624.pub4. Cochrane Database Syst Rev. 2021. PMID: 34378180 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
